Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Remodeling01:40

Bone Remodeling

38.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.5K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanics-free speckle contrast optical spectroscopy with liquid-lens-based adaptive illumination.

Optics letters·2026
Same author

Nervonic acid supplementation mitigates disease severity biomarkers in adrenoleukodystrophy.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same author

Cu<sup>2+</sup>-chelated epigallocatechin gallate nanoparticle-functionalized hydrogel promotes osteogenesis by inhibiting ferroptosis.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

The Application of Selective Intersegmental Laminectomy With Irrigation Technology in the Treatment of Spinal Epidural Abscess.

Orthopaedic surgery·2026
Same author

High-throughput in vitro prediction of available energy in feed ingredients for pigs using a novel computer-controlled digestion system.

Journal of animal science·2026
Same author

Nanomedicine-enabled disruption of glucose metabolism and synergistic antitumor therapy.

Journal of nanobiotechnology·2026

Related Experiment Video

Updated: Sep 10, 2025

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

13.3K

Targeting Irgm1 to combat osteoporosis: suppressing ROS and restoring bone remodeling.

Zichen Cui1, Guanghui Gu1, Fei Chen1

  • 1Department of Orthopedics, The Affiliated Hospital of Qingdao University, Qingdao, China.

Cell Death & Disease
|August 27, 2025
PubMed
Summary

Deleting Immunity-related GTPase family M member 1 (Irgm1) reduces bone loss in osteoporosis by suppressing reactive oxygen species (ROS). This finding suggests Irgm1 as a potential therapeutic target for osteoporosis treatment.

More Related Videos

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

985
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

11.8K

Related Experiment Videos

Last Updated: Sep 10, 2025

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

13.3K
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

985
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

11.8K

Area of Science:

  • Cell Biology
  • Immunology
  • Bone Biology

Background:

  • Reactive oxygen species (ROS) accumulation drives osteoclast activity and bone destruction in postmenopausal osteoporosis.
  • Immunity-related GTPase family M member 1 (Irgm1) influences intracellular ROS production.
  • Elevated Irgm1 levels are observed in osteoporosis models.

Purpose of the Study:

  • To investigate if Irgm1 deletion suppresses osteoclastogenesis via cellular redox regulation.
  • To explore the role of Irgm1 in ovariectomy (OVX)-induced bone loss.
  • To elucidate the molecular mechanisms by which Irgm1 affects bone metabolism.

Main Methods:

  • Evaluation of Irgm1 levels in bone marrow-derived monocytes/macrophages (BMDMs) from OVX mice.
  • Bioinformatics network analysis to identify key genes in osteoclast differentiation.
  • Macrophage-specific Irgm1 knockout (Irgm1-cKO) in OVX mice.
  • Assessment of bone loss, osteoclast differentiation, and bone resorption.
  • Investigation of Irgm1 interaction with Keap1 and Nrf2 pathways.
  • Analysis of osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) and M1 polarization.

Main Results:

  • Irgm1 is a key upregulated gene during osteoclast differentiation.
  • Macrophage-specific Irgm1 knockout significantly slowed bone loss in OVX mice.
  • Loss of Irgm1 inhibited osteoclast differentiation and bone resorption by suppressing ROS accumulation.
  • Irgm1 deficiency led to Keap1 downregulation, Nrf2 nuclear translocation, and activation of the antioxidant system.
  • Irgm1 deficiency promoted BMSC osteogenic differentiation by inhibiting M1 polarization.

Conclusions:

  • Loss of Irgm1 alleviates OVX-induced bone loss by regulating cellular redox balance and inhibiting osteoclastogenesis.
  • Irgm1 deficiency enhances the antioxidant system and promotes osteogenesis.
  • Irgm1 represents a promising novel therapeutic target for osteoporosis treatment.